NCT07241884 SakuraBead Used as Resorbable Embolic for Plantar Fascia Embolization
| NCT ID | NCT07241884 |
| Status | Recruiting |
| Phase | — |
| Sponsor | CrannMed |
| Condition | Plantar Fascitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 45 participants |
| Start Date | 2025-10-20 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 45 participants in total. It began in 2025-10-20 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective, single center, double arm, randomized, unmasked, First in Human study that aims to evaluate the safety and effectiveness of SakuraBead™ resorbable embolization microspheres in adult patients suffering from pain secondary to plantar fasciitis.
Eligibility Criteria
Inclusion Criteria: 1. Patient is able and willing to provide written informed consent, and 2. Age 18 to 75 years (inclusive), and 3. Clinical diagnosis of PF with proximal plantar fascia thickness greater than 4mm and areas of hypoechogenicity. Exclusion Criteria: 1. Acute internal derangement of the foot including acute meniscal, ligament or bone injury, or 2. Sensory or motor neuropathy of the feet, or 3. Heel pain caused by stress fractures, nerve entrapment, or inflammatory conditions such as arthritis, gout, or bursitis, or 4. Prior surgical repair or plantar fascia rupture in the involved foot, or 5. Local infection in either foot, or 6. Contraindication to MRI, or 7. Active pregnancy as demonstrated by urine or serum β-hCG or lactating female 8. Unable to provide informed consent or comply with the conditions of the study, or 9. At the discretion of the Principal Investigator
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07241884 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Plantar Fascitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07241884 currently recruiting?
Yes, NCT07241884 is actively recruiting participants. Contact the research team at joan.mccabe@crannmed.com for enrollment information.
Where is the NCT07241884 trial being conducted?
This trial is being conducted at Tashkent, Uzbekistan.
Who is sponsoring the NCT07241884 clinical trial?
NCT07241884 is sponsored by CrannMed. The trial plans to enroll 45 participants.